Objective: Resistance training (RT) reduces fatigue and improves physical function and quality of life (QOL) in breast cancer survivors (BCS). This may be related to reductions in systemic and tissue-specific inflammation. This pilot study examines the hypothesis that RT induces changes in systemic and tissue-specific inflammation that contribute to improvements in physical and behavioral function in postmenopausal BCS.
T he 10-year survival from breast cancer rose from 65% to 83% in the past 40 years, 1 indicating a prolonged life expectancy. However, most breast cancer survivors (BCS) do not fully recover their premorbid physical and behavioral function, and many develop obesity and diabetes after treatment, 2 suggesting that other factors affect health and recovery. Chronic inflammation is a risk factor for metabolic diseases, and elevated cytokine levels may be one mechanism for fatigue, poor quality of life (QOL), and mobility dysfunction in postmenopausal BCS. 3 There is emerging evidence supporting exercise as a nonpharmacological therapy to prevent cancer recurrence and obesity during cancer survivorship. 4 It seems that interventions that include resistance training (RT) are more efficacious than aerobic exercise in reducing fatigue and improving strength in BCS. 5 To date, most studies show that these responses do not appear to be mediated by changes in systemic inflammation after RT in BCS. [6] [7] [8] However, this may be because the mechanisms regulating the clinical effects of systemic cytokines are tissue-specific such that interleukin (IL)-6 released by skeletal muscle is anti-inflammatory, whereas when secreted by adipose tissue is proinflammatory. 9, 10 This study tests the hypothesis that RT induces tissuespecific and systemic changes in inflammation that contribute to the improvements in strength, physical, and behavioral function in postmenopausal BCS. This would have important implications for attenuating further behavioral and physicalfunctional declines in older BCS.
METHODS

Recruitment and screening
Two hundred eighty nonsmoking, postmenopausal women were recruited from Baltimore, MD, through local newspaper advertisements. Thirty-two generally healthy women (48-75 years old, no menses !12 months) who performed aerobic exercise <30 minutes three times a week, were novice to RT, and had completed treatment for stage I to III breast cancer !1 year before being qualified by phone screening were enrolled. They provided written, informed consent to procedures approved by the IRB of the University of Maryland School of Medicine. Medical examination excluded women with recurrent or active cancer, unstable or painful lymphedema, poorly controlled hypertension or dyslipidemia, heart disease, liver, renal or hematological disease, anemia, orthopaedic, and/or medical conditions that would affect their ability to RT. Eight women were medically ineligible and four were not postmenopausal; thus, 20 BCS underwent baseline testing. Six women withdrew due to time constraints, one had recurrent breast cancer before completing baseline tests, and two were excluded due to noncompliance. The data are reported from the 11 women who completed the intervention. All medications, including treatment with tamoxifen in one and aromatase inhibitors in eight, remained constant.
Baseline and post-testing
Research testing at each time point occurred across five visits that were separated by at least one day: strength testing; VO 2 max; body composition and physical function; oral glucose tolerance test (OGTT) and questionnaires; and tissue biopsies.
Body composition
Body mass index (BMI) was calculated as weight (kg) divided by height (m 2 ). Total body fat (%) and fat-free mass (FFM) were measured by dual-energy x-ray absorptiometry (GE Lunar iDXA, Madison, WI), and visceral and subcutaneous abdominal fat areas at L4-L5 and muscle area at the mid-thigh by computed tomography (Somatom Sensation 64 Scanner; Siemens, Fairfield, CT).
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Strength, physical activity, and functional tests Chair stand time was the fastest time of three trials taken to rise five times from a sitting to a standing position. The 6-minute walk distance (6MWD) was the distance walked quickly on a flat, hard surface in 6 minutes. Gait speed was calculated from a 4-m walk at self-selected walking speed.
One-repetition maximum (1-RM) tests determined chest press, leg press, and leg extension strength on pneumatic RT equipment (Keiser, Fresno, CA) and VO 2 max was measured using a graded treadmill test to maximal exertion as previously described. 12 Participants were instructed to continue to perform their usual physical activities outside of the prescribed RT. This was assessed by measuring average nonstructured total daily physical activity using Actical accelerometers (Philips Respironics, Murrysville, PA) worn for 7 days at baseline and after RT.
Fatigue and quality of life
The revised Piper Fatigue Scale provided an estimate of fatigue, with 0 representing none, 1 to 3 mild, 4 to 6 moderate, and 7 to 10 severe fatigue. 13 The 36-item Short Form Health Survey 14 was used to calculate the two norm-based Physical (PCS) and Mental (MCS) Component Summary scales, with higher values representing better perceived health.
Metabolism and inflammation
All metabolic assessments occurred after a 12-hour fast, and began between 8:00 AM and 9:00 AM. Plasma glucose and insulin profiles during a 2-hour 75 g OGTT and lipids were assessed as previously described. 11 Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) was calculated as ([fasting insulin {[mU/mL} Â fasting glucose {mmol/l}]/ 22.5). 15 Indirect calorimetry (COSMED; Rome, Italy) measured resting metabolic rate (RMR) while participants rested in bed quietly for 30 minutes in a thermo-neutral environment.
Nine BCS agreed to abdominal subcutaneous adipose tissue and vastus lateralis muscle biopsies under local lidocaine anesthesia at baseline and within 36 to 48 hours after the last RT session. Adipose tissue was rinsed free of blood with saline and aliquots of 75 mg were incubated in 1-mL M199 containing 1% BSA at 55 oscillations/min in a 378C water bath. At 3 hours, incubation media were frozen at À708C. Frozen muscle samples were lyophilized for 48 hours and microdissected free of obvious connective tissue. Five milligrams of microdissected muscle was homogenized in 180 mL cold cell lysis buffer containing protease inhibitors (Roche 11836170001), centrifuged at 10,000 g for 5 minutes at 48C, and the supernatant's total protein measured (Coomassie Plus, Pierce). Total protein also was measured in the plasma and incubation media from adipose tissue. In all, 250 mg of total protein for fat and muscle and 1,000 mg of total protein for plasma were added to Human Obesity Antibody Array membranes (abcam ab169819) and incubated overnight to measure plasma and tissue interleukin (IL)-1b, IL-6, and its soluble receptor IL-6sR, IL-8, serum amyloid A (SAA), and tumor necrosis factor-a (TNF-a) and plasma C-reactive protein (CRP). Each membrane contained AE controls for normalization. Pre and post samples were run together on each plate, images exposed using a FluorChem M (ProteinSimple), and data analyzed using Image J software (NIH). The interassay coefficient of variation was 14%. Plasma CRP also was run in duplicate by ELISA using a electrochemiluminescent assay SERRA ET AL (V-PLEX Human CRP Kit, Meso Scale Diagnostics) to compare with standardized values (>3 mg/mL) for chronic inflammation.
Intervention
Progressive, moderate-intensity, whole-body muscle training was performed three times a week for 16 weeks in a research gymnasium supervised by an exercise physiologist to ensure they safely performed the prescribed RT intervention. This involved 15 contractions for two sets and then to exhaustion on the third set for the major muscle groups: leg and chest press, knee extension, leg curl, row, abdominal crunch, and bicep curl for a total duration of 40 to 45 minutes using Keiser equipment. Resistance was gradually increased by the exercise physiologist to account for strength gains and to maximize the intensity of the training when participants were able to complete 20 repetitions on the third set. The increase in weight was individualized based upon the muscle group and physical abilities of the participant. Participants were instructed not to change their dietary habits, which were assessed using pre and postintervention 5-day food records and weekly weights.
Statistical analyses
Wilcoxon signed-rank tests assessed changes in outcome variables and Spearman correlation coefficients assessed the relationships between variables of interest. Results are mean AE SEM, with a two-tailed P value of <0.05 set as significance. Data were analyzed using SPSS (IBM, Version 24, Armonk, New York, NY).
RESULTS
Participant characteristics
The mean (AESEM) age of the 11 BCS (7 Whites, 4 Blacks) was 60 AE 2 years old (range 48-75 years). Mean time after the diagnosis of breast cancer was 10 AE 3 years. The majority of women were overweight or obese (BMI: 30 AE 1 kg/m 2 , range 23-35 kg/m 2 ) and deconditioned (VO 2 max: 24 AE 2 ml/kg/min) ( Table 1) .
Effects of RT on body composition, strength, and physical function
The women attended >80% (85 AE 1%) of prescribed RT sessions without any major adverse effects. RT was associated with an increase in mid-thigh muscle area of 10%, but no changes in body weight, BMI, % body fat, FFM, or visceral or subcutaneous abdominal fat areas (Table 1) .
Resistance training was associated with a 25% to 30% improvement in strength, a 15% decrease in chair stand time, and a 4% increase in 6MWD (Table 1) . Those with the worst strength and physical function at baseline made the greatest improvements (change vs baseline: knee extension 1-RM: r ¼ À0.76, P ¼ 0.03; chair stand time: r ¼ À0.70, P ¼ 0.04; 6MWD: r ¼ À0.50, P ¼ 0.04), and BCS with the greatest reductions in chair stand time had the greatest gains in leg press (r ¼ À0.48, P ¼ 0.04) and knee extension (r ¼ À0.59, P ¼ 0.03) strength. VO 2 max, daily activity counts, RMR, and dietary intake did not change after RT (Table 1) .
Effects of RT on fatigue and quality of life
The mean baseline Piper Fatigue Scale score of 4.5 AE 0.8 indicated moderate fatigue (3 BCS showed severe, 4 moderate, 3 mild, and 1 no fatigue). RT was associated with a 58% decrease in the Piper Fatigue Scale score to 1.9 AE 0.2 (P < 0.01), and BCS with the highest baseline Piper Fatigue Scale score decreased the most (r ¼ À0.95, P < 0.01). None of the women had moderate or severe fatigue by the Piper Fatigue Scale after RT (82% reported mild and 18% reported no fatigue). The baseline MCS and PCS QOL scores were comparable to the US adult referent population.
14 RT was associated with an 8% improvement in the PCS score (50 AE 3 vs 54 AE 2; P ¼ 0.04), but the MCS score did not change (54 AE 3 vs 55 AE 3; P ¼ 0.93). Those with the lowest baseline PCS QOL scores increased the most (r ¼ À0.82, P < 0.01).
Effects of RT on metabolism and inflammation
Hypertension was treated in five women, hypercholesterolemia in three, and three women were insulin-resistant (HOMA-IR !2.5) 16 at baseline. RT was associated with an 18% reduction in fasting insulin (P ¼ 0.04) and an approximately 5% reduction in diastolic and systolic BP (P ¼ 0.04), but there were no changes in fasting and 2-hour glucose, HOMA-IR, or lipids.
Four of the women were chronically inflamed (CRP > 3 mg/mL) at baseline by ELISA-measured CRP. RT reduced plasma CRP comparable amounts measured by ELISA (pre vs post: 3.0 AE 0.4 vs 2.2 AE 0.5 mg/mL; À27 AE 16%, P ¼ 0.18) or antibody array (À28 AE 17%, P ¼ 0.31). RT decreased relative protein content of TNF-a, IL-6sR, and SAA in plasma and adipose tissue secretions on average by approximately 25% to 35% (Fig. 1) , and the absolute changes were greatest in those with the highest baseline inflammatory protein concentrations (plasma: TNF-a: r ¼ À0.52, P ¼ 0.04; IL-6sR: r ¼ À0.77, P < 0.01; SAA: r ¼ À0.49, P ¼ 0.04; adipose tissue secretions: TNF-a: r ¼ À0.64, P ¼ 0.03; IL-6sR: r ¼ À0.83, P < 0.01; SAA: r ¼ À0.63, P ¼ 0.04). Skeletal muscle protein content of IL-8 increased on average 75 AE 29% (P ¼ 0.03), and the absolute change correlated positively with increases in leg press strength (r ¼ 0.53, P ¼ 0.04). There were reductions in myokines IL-6 and SAA in six of nine women, with an overall mean changes of À11% (P ¼ 0.10) and À18% (P ¼ 0.12), respectively. Changes in the other myokines were variable and did not approach significance (Fig. 1) .
DISCUSSION
There is considerable evidence supporting the hypothesis that chronic inflammation is associated with fatigue, poorer QOL, and reduced physical function in BCS. 3, 17 The results of this study show that a progressive, well-supervised RT program is associated with increased muscle mass, improved physical function and QOL, and reduced fatigue in postmenopausal BCS. The changes in inflammation with RT appear to be tissue-specific, with reductions in the proinflammatory cytokines TNF-a, IL-6sR, and SAA in both plasma and adipose tissue and increases in the proproliferative IL-8 in muscle that parallel the reductions in fatigue, and improvements in physical function and behavioral profiles. The finding that the BCS with the highest cytokine levels and worst baseline psychological and physical function derive the greatest health benefits from RT suggests that there is potential for these improvements to occur across a broad range of physiological and psychological dysfunction in BCS. 
SERRA ET AL
Whereas other RT studies demonstrate variable effects on cytokines in BCS, most measured only plasma cytokines, and there was concomitant weight loss, which obscured the independent effects of RT. 7 Further, the finding that the largest reductions in systemic cytokines with RT are observed in more obese women 18, 19 could explain the failure of RT to reduce plasma inflammation in lean and overweight middleaged 20 and postmenopausal 7, 21 BCS seen previously. Adipose tissue produces both pro and anti-inflammatory mediators that influence the regulation of metabolic, immune, and regenerative processes. Proinflammatory adipokines increase with age and obesity, and are associated with lower muscle mass and strength, physical disability, and worse metabolic health in older adults. 22 The ability of RT to reduce adipokines and systemic cytokines could ameliorate the adverse effects of chronic inflammation, potentially prolonging functional independence and QOL in BCS. 23 Previous studies examining the effects of RT on proinflammatory cytokines in skeletal muscle show inconsistent results, reporting both increases 24, 25 and decreases 26, 27 across various populations of older adults. Some studies show reductions in proinflammatory markers with exercise training in adipose tissue, but not muscle, 28 and vice versa. 25 These discrepancies may be attributed to differences in the population studied (ie, age, hormonal status, and comorbidities), RT intensity and duration, and changes in body weight. The increase observed in the myokine IL-8 in this study, a chemotactic factor that stimulates angiogenesis, 10 could have pro-proliferative effects to augment muscle protein synthesis as suggested by the direct relationship seen between increases in lower-extremity strength and IL-8 levels, and studies that show RT increases systemic and muscle IL-8. 29 Strengths of this study are the high rate of compliance, stability of diet, weight and activity of the participants, and microdissection of muscle before cytokine measurement. Limitations include the small sample size and lack of follow-up, which should be considered in the design of future trials. The possibility of regression to the mean should be considered to avoid making incorrect inferences in the interpretation of these data. This limitation would have been avoided by randomization to a comparison group; nevertheless, the magnitude of the physical and behavioral improvements observed in these BCS in response to a carefully supervised resistive exercise training program is substantial and clinically relevant.
CONCLUSIONS
These findings support progressive RT as a strategy to offset the negative behavioral functional effects of breast cancer treatment that adversely affects the lifestyle of older BCS. This program can be accomplished at gymnasiums with standard strength training equipment; thus, it would be practical to conduct larger, community-based trials to confirm these preliminary findings and assess the longer-term healthrelated benefits of RT in more BCS. Future studies also should consider the randomization of participants to appropriate control groups and the combined effects of RT with other lifestyle interventions, including aerobic exercise and dietary modification.
